The structure of the human 4F2hc-LAT1 heteromeric amino acid transporter

  • Dimitrios FotiadisEmail author
  • Jean-Marc Jeckelmann


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Cheng, Y., Grigorieff, N., Penczek, P.A., and Walz, T. (2015). A primer to single-particle cryo-electron microscopy. Cell 161, 438–449.CrossRefGoogle Scholar
  2. Chien, H.C., Colas, C., Finke, K., Springer, S., Stoner, L., Zur, A.A., Venteicher, B., Campbell, J., Hall, C., Flint, A., et al. (2018). Reevaluating the substrate specificity of the L-type amino acid transporter (LAT1). J Med Chem 61, 7358–7373.CrossRefGoogle Scholar
  3. Fort, J., de la Ballina, L.R., Burghardt, H.E., Ferrer-Costa, C., Turnay, J., Ferrer-Orta, C., Usón, I., Zorzano, A., Fernández-Recio, J., Orozco, M., et al. (2007). The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane. J Biol Chem 282, 31444–31452.CrossRefGoogle Scholar
  4. Fotiadis, D., Kanai, Y., and Palacín, M. (2013). The SLC3 and SLC7 families of amino acid transporters. Mol Aspects Med 34, 139–158.CrossRefGoogle Scholar
  5. Geier, E.G., Schlessinger, A., Fan, H., Gable, J.E., Irwin, J.J., Sali, A., and Giacomini, K.M. (2013). Structure-based ligand discovery for the large-neutral amino acid transporter 1, LAT-1. Proc Natl Acad Sci USA 110, 5480–5485.CrossRefGoogle Scholar
  6. Ilgü, H., Jeckelmann, J.-M., Colas, C., Ucurum, Z., Schlessinger, A., and Fotiadis, D. (2018). Effects of mutations and ligands on the thermostability of the L-arginine/agmatine antiporter AdiC and deduced insights into ligand-binding of human L-type amino acid transporters. IJMS 19, 918.CrossRefGoogle Scholar
  7. Ilgü, H., Jeckelmann, J.-M., Gapsys, V., Ucurum, Z., de Groot, B.L., and Fotiadis, D. (2016). Insights into the molecular basis for substrate binding and specificity of the wild-type L-arginine/agmatine antiporter AdiC. Proc Natl Acad Sci USA 113, 10358–10363.CrossRefGoogle Scholar
  8. Jeckelmann, J.-M., and Fotiadis, D. (2019). Volta phase plate cryo-EM structure of the human heterodimeric amino acid transporter 4F2hc-LAT2. IJMS 20, 931.CrossRefGoogle Scholar
  9. Meury, M., Costa, M., Harder, D., Stauffer, M., Jeckelmann, J.-M., Brühlmann, B., Rosell, A., Ilgü, H., Kovar, K., Palacín, M., et al. (2014). Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2. PLoS ONE 9, e109882.CrossRefGoogle Scholar
  10. Nii, T., Segawa, H., Taketani, Y., Tani, Y., Ohkido, M., Kishida, S., Ito, M., Endou, H., Kanai, Y., Takeda, E., et al. (2001). Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation. Biochem J 358, 693–704.CrossRefGoogle Scholar
  11. Rosell, A., Meury, M., Álvarez-Marimon, E., Costa, M., Pérez-Cano, L., Zorzano, A., Fernández-Recio, J., Palacín, M., and Fotiadis, D. (2014). Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc. Proc Natl Acad Sci USA 111, 2966–2971.CrossRefGoogle Scholar
  12. Scalise, M., Galluccio, M., Console, L., Pochini, L., and Indiveri, C. (2018). The human SLC7A5 (LAT1): The intriguing histidine/large neutral amino acid transporter and its relevance to human health. Front Chem 6, 243.CrossRefGoogle Scholar
  13. Tărlungeanu, D.C., Deliu, E., Dotter, C.P., Kara, M., Janiesch, P.C., Scalise, M., Galluccio, M., Tesulov, M., Morelli, E., Sonmez, F.M., etal. (2016). Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell 167, 1481–1494.e18.CrossRefGoogle Scholar
  14. Yan, R., Zhao, X., Lei, J., and Zhou, Q. (2019). Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex. Nature 568, 127–130.CrossRefGoogle Scholar
  15. Zur, A.A., Chien, H.C., Augustyn, E., Flint, A., Heeren, N., Finke, K., Hernandez, C., Hansen, L., Miller, S., Lin, L., et al. (2016). LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates. BioOrg Medicinal Chem Lett 26, 5000–5006.CrossRefGoogle Scholar

Copyright information

© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institute of Biochemistry and Molecular Medicine, and Swiss National Centre of Competence in Research (NCCR) TransCureUniversity of BernBernSwitzerland

Personalised recommendations